Nordea Investment Management AB Trims Stock Position in Danaher Corporation $DHR

Key Points

• Nordea Investment Management AB has reduced its stake in Danaher Corporation by 1.1%, owning approximately 1,763,580 shares valued at $352.2 million as of the latest SEC filing.
• Analysts have varied price targets for Danaher, with Evercore ISI upgrading its target to $245, while Wells Fargo lowered its target to $205.
• Danaher recently announced a quarterly dividend of $0.32 per share, representing an annualized yield of 0.6% and a payout ratio of 27.23%.

Nordea Investment Management AB lessened its holdings in shares of Danaher Corporation (NYSE:DHR - Free Report) by 1.1% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,763,580 shares of the conglomerate's stock after selling 19,955 shares during the period. Nordea Investment Management AB owned approximately 0.25% of Danaher worth $352,222,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors have also recently made changes to their positions in the company. GHP Investment Advisors Inc. grew its position in Danaher by 396.0% during the first quarter. GHP Investment Advisors Inc. now owns 124 shares of the conglomerate's stock valued at $25,000 after buying an additional 99 shares during the period. Sierra Ocean LLC grew its position in Danaher by 116.9% during the first quarter. Sierra Ocean LLC now owns 141 shares of the conglomerate's stock valued at $29,000 after buying an additional 76 shares during the period. Red Tortoise LLC grew its position in Danaher by 175.0% during the second quarter. Red Tortoise LLC now owns 154 shares of the conglomerate's stock valued at $30,000 after buying an additional 98 shares during the period. Smallwood Wealth Investment Management LLC acquired a new stake in Danaher during the first quarter valued at $31,000. Finally, Dunhill Financial LLC grew its position in Danaher by 68.4% during the first quarter. Dunhill Financial LLC now owns 165 shares of the conglomerate's stock valued at $34,000 after buying an additional 67 shares during the period. Hedge funds and other institutional investors own 79.05% of the company's stock.

Wall Street Analyst Weigh In

Several analysts recently commented on the stock. Redburn Partners set a $220.00 price target on shares of Danaher in a research report on Wednesday, October 8th. Wells Fargo & Company dropped their price target on shares of Danaher from $210.00 to $205.00 and set an "equal weight" rating on the stock in a research report on Wednesday, July 23rd. Royal Bank Of Canada set a $241.00 price target on shares of Danaher in a research report on Tuesday, September 2nd. Evercore ISI raised their price target on shares of Danaher from $226.00 to $245.00 and gave the company an "outperform" rating in a research report on Tuesday, October 7th. Finally, Barclays reiterated an "overweight" rating and issued a $225.00 target price (up previously from $215.00) on shares of Danaher in a research report on Tuesday, June 24th. Seventeen investment analysts have rated the stock with a Buy rating and six have given a Hold rating to the company. According to MarketBeat, Danaher presently has a consensus rating of "Moderate Buy" and an average target price of $244.60.

Insiders Place Their Bets

In related news, Director Teri List sold 2,778 shares of the business's stock in a transaction dated Friday, August 22nd. The shares were sold at an average price of $211.06, for a total transaction of $586,324.68. Following the transaction, the director directly owned 20,751 shares in the company, valued at approximately $4,379,706.06. The trade was a 11.81% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Insiders own 11.10% of the company's stock.

Danaher Stock Up 2.3%

Shares of NYSE DHR opened at $210.86 on Friday. The firm has a market cap of $150.99 billion, a price-to-earnings ratio of 44.86, a price-to-earnings-growth ratio of 2.94 and a beta of 0.77. Danaher Corporation has a 52-week low of $171.00 and a 52-week high of $279.41. The company's 50-day simple moving average is $201.43 and its 200-day simple moving average is $197.23. The company has a quick ratio of 1.22, a current ratio of 1.62 and a debt-to-equity ratio of 0.32.

Danaher (NYSE:DHR - Get Free Report) last posted its quarterly earnings results on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share for the quarter, topping analysts' consensus estimates of $1.64 by $0.16. The firm had revenue of $5.94 billion for the quarter, compared to analyst estimates of $5.83 billion. Danaher had a net margin of 14.21% and a return on equity of 10.70%. Danaher's quarterly revenue was up 3.4% on a year-over-year basis. During the same period in the previous year, the business posted $1.72 earnings per share. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. Equities analysts predict that Danaher Corporation will post 7.63 EPS for the current fiscal year.

Danaher Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Investors of record on Friday, September 26th will be given a dividend of $0.32 per share. The ex-dividend date is Friday, September 26th. This represents a $1.28 dividend on an annualized basis and a yield of 0.6%. Danaher's payout ratio is presently 27.23%.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.